Improving pregnancy outcomes in humans through studies in sheep

JL Morrison, MJ Berry, KJ Botting… - American Journal …, 2018 - journals.physiology.org
Experimental studies that are relevant to human pregnancy rely on the selection of
appropriate animal models as an important element in experimental design. Consideration …

Antenatal corticosteroids: a reappraisal of the drug formulation and dose

AH Jobe, M Kemp, A Schmidt, T Takahashi… - Pediatric …, 2021 - nature.com
We review the history of antenatal corticosteroid therapy (ACS) and present recent
experimental data to demonstrate that this, one of the pillars of perinatal care, has been …

Antenatal corticosteroids: an assessment of anticipated benefits and potential risks

AH Jobe, RL Goldenberg - American journal of obstetrics and gynecology, 2018 - Elsevier
Antenatal corticosteroids are standard of care for pregnancies at risk of preterm delivery
between 24-34 weeks' gestational age. Recent trials demonstrate modest benefits from …

No. 364-Antenatal corticosteroid therapy for improving neonatal outcomes.

A Skoll, A Boutin, E Bujold, J Burrows… - Journal of Obstetrics …, 2018 - europepmc.org
No. 364-Antenatal Corticosteroid Therapy for Improving Neonatal Outcomes. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

[HTML][HTML] Low-dose betamethasone-acetate for fetal lung maturation in preterm sheep

AF Schmidt, MW Kemp, J Rittenschober-Böhm… - American journal of …, 2018 - Elsevier
Background Antenatal steroids are standard of care for women who are at risk of preterm
delivery; however, antenatal steroid dosing and formulation have not been evaluated …

Antenatal steroids elicited neurodegenerative-associated transcriptional changes in the hippocampus of preterm fetal sheep independent of lung maturation

SWD Carter, EL Fee, H Usuda, G Oguz, A Ramasamy… - BMC medicine, 2024 - Springer
Background Antenatal steroid therapy for fetal lung maturation is routinely administered to
women at risk of preterm delivery. There is strong evidence to demonstrate benefit from …

Optimizing antenatal corticosteroid therapy

MW Kemp, AF Schmidt, AH Jobe - Seminars in Fetal and Neonatal …, 2019 - Elsevier
Abstract Treatment with antenatal corticosteroids (ACS) is standard of care for women at risk
of preterm birth between 24 and 34 weeks' gestation. ACS are increasingly used for other …

The efficacy of antenatal steroid therapy is dependent on the duration of low-concentration fetal exposure: evidence from a sheep model of pregnancy

MW Kemp, M Saito, H Usuda, S Watanabe… - American journal of …, 2018 - Elsevier
Background Antenatal corticosteroids are among the most important and widely used
interventions to improve outcomes for preterm infants. Antenatal corticosteroid dosing …

Betamethasone phosphate reduces the efficacy of antenatal steroid therapy and is associated with lower birthweights when administered to pregnant sheep in …

T Takahashi, EL Fee, Y Takahashi, M Saito… - American journal of …, 2022 - Elsevier
Background Antenatal corticosteroid therapy is a standard of care for women at imminent
risk of preterm labor. However, the optimal (maximum benefit and minimal risk of side …

Evaluation of maternal drug exposure following the administration of antenatal corticosteroids during late pregnancy using physiologically‐based pharmacokinetic …

AB Ke, MA Milad - Clinical Pharmacology & Therapeutics, 2019 - Wiley Online Library
Betamethasone and dexamethasone are the most widely studied antenatal corticosteroids
(ACS) administered to pregnant women, just prior to the birth of a preterm neonate, to …